Patent 7652033 was granted and assigned to Emory University on January, 2010 by the United States Patent and Trademark Office.
HIF-1 inhibitors and methods of their use are provided. In particular, 2,2-dimethylbenzopyran based compounds and methods of their use, for example in the treatment or prevention of hypoxia-related pathologies are provided.